One day before the fatal Friday13, Hana Biosciences, Inc. (OTC:HNAB) stock dived to its new 52-week low. It seems that the latest special meeting of the company's stockholders and the announcement of the fourth Warburg Pincus’ director designee were not appreciated by investors.read more